Human GIL-19/AE289 proteins and polynucleotides encoding same

Details for Australian Patent Application No. 2003262307 (hide)

Owner Genetics Institute, LLC

Inventors Jacobs, Kenneth; Xuan, Dejun; Fouser, Lynette; Spaulding, Vikki

Agent Davies Collison Cave

Pub. Number AU-B-2003262307

Parent 764191

Filing date 12 November 2003

Wipo publication date 11 December 2003

Acceptance publication date 22 March 2007

International Classifications

C12P 21/06 (2006.01) Preparation of peptides or proteins - produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 1/00 (2006.01) General processes for the preparation of peptides

C07K 2/00 (2006.01) Peptides of undefined number of amino acids

C07K 4/00 (2006.01) Peptides having up to 20 amino acids in an undefined or only partially defined sequence

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

27 November 2003 Complete Application Filed

11 December 2003 Application Open to Public Inspection

  Published as AU-B-2003262307

22 March 2007 Application Accepted

  Published as AU-B-2003262307

4 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003262308-Windshield Wiper System Activated by Sensing Rainwater

2003262306-Logistics Chain Management System